Evidence map›Paper›PMID 38300499›Full record

ReviewActa parasitologica2024

Irritable Bowel Syndrome Associated with Blastocystis hominis or Without Relationship to It? A Case-Control Study and Minireview.

Amir Hossein Maghsood, Shaghayegh Kayedimajd, Seyedmousa Motavallihaghi, Rohallah Abedian, Shirafkan Kordi, Lotfollah Davoodi, Fariba Faizi, Eissa Soleymani

Abstract readReview
PubMed Publisher
In one paragraph

Review in Acta parasitologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Amir Hossein MaghsoodDepartment of Medical Mycology and Parasitology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Shaghayegh KayedimajdDepartment of Gastroenterology, Darlington Memorial Teaching Hospital, Durham, UK.
Seyedmousa MotavallihaghiDepartment of Medical Mycology and Parasitology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Rohallah AbedianDepartment of Infectious Diseases, Antimicrobial Resistance Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Shirafkan KordiDepartment of Infectious Diseases, Antimicrobial Resistance Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Lotfollah DavoodiDepartment of Infectious Diseases, Antimicrobial Resistance Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Fariba FaiziDepartment of Medical Mycology and Parasitology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Eissa SoleymaniDepartment of Medical Mycology and Parasitology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. Eissa_Soleymani@Yahoo.com.ORCID http://orcid.org/0000-0003-3035-0928
Hamedan University of Medical Sciences · IRMazandaran University of Medical Sciences · IRDarlington Memorial Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBlastocystis hominis (B. hominis) is a protozoan parasite that has a worldwide distribution. Some studies have suggested a link between B. hominis and the development of irritable bowel syndrome (IBS). The objective of this study was to determine the prevalence of B. hominis in patients with IBS compared to healthy individuals. MATERIAL AND

methodsA total of 65 stool samples from patients with IBS and 65 samples from healthy individuals in northern Iran were examined. The samples were tested using various methods including direct smear, formalin ether sedimentation and culture to detect the presence of B. hominis. Additionally, polymerase chain reaction (PCR) was performed on all culture-positive isolates to confirm the results and identify the genotype.

resultsB. hominis was detected in 15.38% of IBS patients and 9.2% of the healthy group. The culture in RPMI1640 was found to be better than the formalin ether and direct smear methods. Positive samples were confirmed using the molecular method. No significant difference was observed in the order of B. hominis infection between the two groups.

conclusionsThe results of our study indicate that no significant difference was observed in the order of B. hominis infection between IBS patients and healthy groups. Therefore, further study is necessary to determine the potential pathogenic effects of this parasite and its role in causing IBS.

Indexed as

Blastocystis hominisBlastocystis InfectionsIrritable Bowel SyndromeAdolescentAdultCase-Control StudiesFecesFemaleHumansIranMaleMiddle AgedPolymerase Chain ReactionPrevalenceYoung AdultBlastocystis hominisBlastocystosisIranIrritable bowel syndromeSubtype

Identifiers

PMID38300499
OpenAlexW4391430929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.